Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

129-43-1

1-Hydroxyanthraquinone

129-43-1
51-17-2

Benzimidazol

51-17-2
120-51-4

Benzyl benzoate

120-51-4
611-75-6

Bromhexine HCL

611-75-6
41859-67-0

Bezafibrate

41859-67-0
1812-30-2

Bromazepam

1812-30-2
487-93-4

Bufotenine

487-93-4
106-51-4

Benzoquinone-1,4

106-51-4
3543-75-7

Bendamustine HCl

3543-75-7
153559-49-0

Bexarotene

153559-49-0
179324-69-7

Bortezomib libre

179324-69-7
55-98-1

Busulfan

55-98-1
491-80-5

Biochanin A

491-80-5
104344-23-2

Bisoprolol Hemifumarate

104344-23-2
35543-24-9

Buflomedil HCl

35543-24-9
103597-45-1

Bisoctrizole

103597-45-1
5716-20-1

Bamethane hemisulfate salt

5716-20-1
153012-65-8

Bumetanide-N-Desbutyl-N-(2-ethylhexyl)

153012-65-8
74174-44-0

Brassinolide ethyl

74174-44-0
55206-22-9

Bufotenine HCl

55206-22-9